These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6226358

  • 1. Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study.
    Andelman SY.
    Clin Ther; 1983; 5(6):651-61. PubMed ID: 6226358
    [Abstract] [Full Text] [Related]

  • 2. Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis.
    del Toro RA, Concepción R.
    Clin Ther; 1983; 5(4):436-44. PubMed ID: 6223699
    [Abstract] [Full Text] [Related]

  • 3. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
    Edwards W.
    Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
    [Abstract] [Full Text] [Related]

  • 4. Etodolac in postsurgical pain: a double-blind dose-ranging efficacy study with aspirin and placebo.
    Versichelen L, Bilsback P, Rolly G, Merlo M, Joubert L.
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):236-9. PubMed ID: 6212554
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
    Dick WC, Bulstra S, Schardijn GH, Feenstra RM.
    Clin Ther; 1992 May; 14(4):517-26. PubMed ID: 1388092
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients.
    Vetter G, Placchi M, Joubert L.
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):240-5. PubMed ID: 6212555
    [Abstract] [Full Text] [Related]

  • 7. Relief of dental surgery pain: a controlled 12-hour comparison of etodolac, aspirin, and placebo.
    Nelson SL, Bergman SA.
    Anesth Prog; 1985 May; 32(4):151-6. PubMed ID: 2934008
    [Abstract] [Full Text] [Related]

  • 8. Comparison of etodolac and diclofenac in osteoarthritis of the knee.
    Grisanti AM, Vaz AA, Samara AM.
    Clin Ther; 1992 May; 14(6):791-800. PubMed ID: 1286486
    [Abstract] [Full Text] [Related]

  • 9. Multicenter studies in the United States and Canada of meclofenamate sodium in osteoarthritis of the hip and knee. Double-blind comparison with placebo and long-term experience.
    Petrick TJ, Bovenkerk WE.
    Arzneimittelforschung; 1983 May; 33(4A):644-8. PubMed ID: 6349649
    [Abstract] [Full Text] [Related]

  • 10. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
    Altman RD, Moskowitz R.
    J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
    Liang TH, Hsu PN.
    Curr Med Res Opin; 2003 Nov; 19(4):336-41. PubMed ID: 12841927
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F.
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [Abstract] [Full Text] [Related]

  • 13. Activated osteoarthrosis (osteoarthritis) and its treatment with indomethacin and benoxaprofen: a double-blind crossover study.
    Bach GL.
    Eur J Rheumatol Inflamm; 1982 Nov; 5(2):224-9. PubMed ID: 7044797
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R.
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [Abstract] [Full Text] [Related]

  • 15. Low dose etodolac in rheumatoid arthritis: a review of early studies.
    Spencer-Green G.
    J Rheumatol Suppl; 1997 Feb; 47():3-9; discussion 48-50. PubMed ID: 9035014
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
    Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A.
    Rev Rhum Engl Ed; 1997 Dec; 64(12):825-34. PubMed ID: 9476272
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis.
    Puccetti L, Ciompi ML.
    Int J Clin Pharmacol Res; 1991 Dec; 11(3):143-58. PubMed ID: 1839736
    [Abstract] [Full Text] [Related]

  • 18. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
    Detora LM, Krupa D, Bolognese J, Sperling RS, Ehrich EW.
    J Rheumatol; 2001 Nov; 28(11):2494-503. PubMed ID: 11708424
    [Abstract] [Full Text] [Related]

  • 19. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries.
    D'Hooghe M.
    Clin Ther; 1992 Nov; 14(4):507-16. PubMed ID: 1388091
    [Abstract] [Full Text] [Related]

  • 20. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.